JBTM
JBT Marel Corporation
JBTM has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has a slight edge over JBTM overall, supported by stronger valuation and stronger modeled upside.
JBTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
JBTM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
JBTM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $41.41 | -67% |
| Forward | 14x | $125 | — |
| Fair | 28x | $104 | -17% |
| Current | 33x | $125 | — |
| Expensive | 41x | $153 | +22% |
Historical ranges are pointers, not guarantees.
JBTM's PE is in its expensive range at 33x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
JBTM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect JBTM's earnings to grow and its profitability to improve, with its revenue holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over JBTM on the outlook, with more favorable revenue expectations.
JBTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.08 | +140% |
| Q3 2026 | $3.78 | +$6.02 |
| Q2 2026 | $3.70 | +$5.99 |
| Q1 2026 | $3.23 | +$4.64 |
| Q4 2025 | -$0.98 | -137% |
| Q3 2025 | -$2.24 | -142% |
| Q2 2025 | -$2.29 | -112% |
| Q1 2025 | -$1.41 | -108% |
| Q4 2024 | $2.65 | -86% |
JBTM has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
JBTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $994M | -0.7% |
| Q2 2026 | $981M | +4.9% |
| Q1 2026 | $936M | +9.6% |
| Q4 2025 | $1B | +116% |
| Q3 2025 | $1B | +121% |
| Q2 2025 | $934.8M | +132% |
| Q1 2025 | $854.1M | +118% |
| Q4 2024 | $467.6M | +5.2% |
JBTM's revenue is growing: $994M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -0.1 points |
| Q2 2026 | 4.7% | -0.5 points |
| Q1 2026 | 7.3% | +11 points |
| Q4 2025 | 7.2% | +3.8 points |
| Q3 2025 | 10% | -0.1 points |
| Q2 2025 | 5.2% | -1.5 points |
| Q1 2025 | -3.9% | -11 points |
| Q4 2024 | 3.4% | -9.6 points |
JBTM has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
JBTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $73M | +29% |
| Q2 2026 | $77M | -8% |
| Q1 2026 | $93M | +546% |
| Q4 2025 | $83.5M | -30% |
| Q3 2025 | $56.5M | -13% |
| Q2 2025 | $83.7M | +654% |
| Q1 2025 | $14.4M | +$14.5M |
| Q4 2024 | $118.7M | +$149M |
JBTM has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
JBTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -600K shares |
| 1 year | -1.3% | -700K shares |
| 3 years | +61% | +19.5M shares |
| 5 years | +61% | +19.5M shares |
| Available history | +61% | +19.5M shares |
JBTM has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $94M |
| Q4 2023 | $5.1M |
| Q3 2023 | — |
| Q4 2022 | $4.9M |
| Q3 2022 | $500,000 |
| Q4 2019 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
JBTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.6x | Very low |
| Q2 2024 | 1.0x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 0.8x | Very low |
| Q3 2023 | 1.2x | Healthy |
| Q2 2023 | 4.1x | High |
| Q1 2023 | 4.2x | High |
JBTM's net debt is less than a year of its operating earnings (EBITDA).
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JBTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 51.7 | Neutral |
JBTM's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
JBTM PE vs Industrials Sector
| Metric | JBTM | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 24x | 38% above |
| PE % | 73 | 58 | 15 pts above |
JBTM is trading at 33x earnings, a 38% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
JBTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $112.7 | 11% above |
| 20 week MA | $120.7 | 3.7% above |
| 50 week MA | $133.2 | 6% below |
| 100 week MA | $130.0 | 3.7% below |
| 200 week MA | $117.0 | 7% above |
JBTM's trend is mixed: it's above three of its five weekly moving averages, and 7% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
JBTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $114.8 | $117.8 | +2.6% |
| 2021 | $117.8 | $153.0 | +30% |
| 2022 | $153.0 | $89.2 | -42% |
| 2023 | $89.2 | $99.5 | +11% |
| 2024 | $99.5 | $128.4 | +29% |
| 2025 | $128.4 | $155.1 | +21% |
| 2026 YTD | $155.1 | $125.2 | -19% |
JBTM has finished higher in five of the last six years. It's down 19% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over JBTM on returns for 2026, with the stronger performance.